October 24, 2015 6 prescription mistakes you’re making It’s hard to imagine a time when there wasn’t a pill—sometimes dozens of different ones—to treat so many health conditions.
October 24, 2015 Merck antibody reduces risk of Clostridium difficile recurrence, study says An experimental antibody developed by Merck & Co Inc was shown in pivotal studies to reduce by about 10 percentage points the risk that infection with Clostridium difficile bacterium, which can cause a deadly diarrhea, will recur.
October 24, 2015 The time to get a flu shot is now This year the National Foundation of Infectious Diseases (NFID) is out ahead of the flu season. Yesterday’s conference in Washington D.C. was all about vaccination, and there are now more options than ever before.
October 24, 2015 Erectile dysfunction drug Cialis seeking over-the-counter approval If two large drug makers get their way, consumers may be able to buy the impotence drug Cialis directly off a pharmacy shelf in a few years' time, without a doctor's prescription.
October 24, 2015 Millions of dollars wasted on flu drug Tamiflu, review finds Researchers who have fought for years to get full data on Roche's flu medicine Tamiflu said on Thursday that governments who stockpile it are wasting billions of dollars on a drug whose effectiveness is in doubt.
October 24, 2015 Database study hints diabetes drug cuts Alzheimer's risk A large German study is the latest clinical trial to suggest that a cheap generic treatment for diabetes can stave off symptoms of Alzheimer's disease, although conclusive proof from a more formal trial could be about five years away.
October 24, 2015 Study shows drug combination can treat bipolar depression NeuroRx Inc said initial results of a small study show a combination of several drugs can reduce symptoms of depression and suicidal tendencies in patients with bipolar disorder and maintain that effect over time.
October 24, 2015 Hepatitis patients often ‘fall off’ the treatment path Many people with hepatitis C end up not receiving adequate treatment, because they lose their way through the medical system during the early stages of their care, researchers say.
October 24, 2015 FDA studies possible pre-cancerous link with diabetes drugs The Food and Drug Administration is studying unconfirmed reports that a widely used class of diabetes drugs, which includes Merck & Co's Januvia, may cause inflammation of the pancreas and pre-cancerous changes to the pancreas
October 24, 2015 Lilly's psoriatic arthritis drug succeeds in late-stage study Eli Lilly and Co said its experimental drug, ixekizumab, reduced the signs and symptoms of active psoriatic arthritis in patients more than a placebo did in a late-stage trial.
